Manage client interaction and monitor market and business trends for opportunities. Transaction execution: Lead sourcing, networking for buy-side interest, negotiation of term sheets, reserved matters, valuation, deal structuring, SSA, SHA and Due Diligence to successful closing of transaction.Origination: Generate new business opportunities. Manage existing relationships and create new ones. Independently execute deals from beginning to end. Ensure projects are managed appropriately, internal processes adhered to, and tasks delegated and reviewed timely. IPO transactions: Lead team on preparing disclosure documents including prospectus. Interact with members of the Exchange and SEC on behalf of clients on listing criteria and disclosure requirements. Advise on Equity Story, Corporate Governance and Management Discussion and Analysis. Supervise valuation and pricing. Negotiate terms for underwriting. M&A and Private Placement Transactions: Negotiate advisory and success fees, and execute contracts. Lead team on preparation of Financial Model, Information Memorandum and development of Data Room. Develop strategies to secure investors’ interest, build relationships and networks to disseminate information and solicit interests. Present clients’ information at road shows. Develop Deal Structure. Supervise valuation (DCF models / Comparable companies). Lead discussion for reserved matters, valuation, structuring, shareholder agreement with buy-side or investors. Corporate Finance Advisory (Corporate Governance, Valuation, Restructuring and DD): Supervise and guide members of Corporate Finance Advisory Team. Advise on structure, selection and qualification and rules and responsibilities of Board Members. Present Corporate Governance theories and practices to the clients’ Board. Oversee valuation, restructuring and Due Diligence projects and present to the clients’ Board.

Led IPO project teams on three IPO mandates: FMI (First Myanmar Investment), AGD Bank and MAPCO). Successfully facilitated the first ever company listing on the Yangon Stock Exchange (YSX). Developed new leads and managed risks associated with high profile listings. Managed company's PR relations and external communications. Collaborated with YSX and SEC members. Managed listing clients and routinely presented on listing progress. Successfully managed external professionals such as legal and accounting advisors in producing disclosure documents for listing (DDL). Influenced Board and key stake holders on disclosure documents.Supervised underwriting due diligence processes.

Led advisory team on IPO projects.

Contributed to rollout of new T&E system. Established the base line "current state" and garnered "future state" by customer survey. Generated automated financial reports for T&E transactions.Managed CROs to deliver quality services for critical projects. Successfully reduced the deliverable time by eliminating non-value added activities and streamlining processesRoutinely evaluated and proposed new CROs opportunities, performed due diligence, and creatively developed and executed CROs opportunities to realityPerform complex data analyses to draw insights and actionable recommendationsUtilized Lean Six Sigma green belt training in managing external research collaborations, successfully established a database to track proposals and to generate reports by collaborating with IS organization

• Creatively and independently designed, developed and executed concepts to reality• Relentlessly prioritized and drove projects to achieve milestones in less than allotted time • Effectively collaborated with colleagues from cross functions to achieve set goals. • Performed due diligence on project’s potential and pitfalls. • Served as subject matter expert in many project teams. • Train and supervise junior staffs.

Created comprehensive and executable business development and marketing plans for Lower East Side Business Improvement District.• Performed business and benchmarking analysis of eight other business improvement districts• Identified and formulated strategies to bridge business gaps using primary research data• Presented recommendations to executive director

Protein engineering and assay development of protease inhibitor Cucurbita maxima Trypsin Inhibitor-V (CMTI-V). Site directed mutagenesis, protein expression and purification, enzymatic assay, sequencing and protein modeling.

Experience includes tissue culture (U937 and RAW264.7), iNOS assay, EMSA